Management of CKD Stage 3a/3b

Diagnostic Evaluation

• The American Diabetes Association recommends immediately checking urine albumin-to-creatinine ratio (ACR) to assess kidney damage and guide treatment intensity, with ACR ≥30 mg/g indicating kidney damage requiring ACE inhibitor or ARB therapy, and ACR ≥300 mg/g strongly indicating need for renin-angiotensin system blockade 1
• The European Heart Association suggests that urine albumin-to-creatinine ratio (ACR) is mandatory at this stage to assess kidney damage and guide treatment intensity, with persistent albuminuria predicting cardiovascular events and progressive kidney disease 3, 4
• Comprehensive metabolic evaluation should include urinalysis to detect proteinuria, hematuria, or casts that would indicate intrinsic kidney disease, although this fact is from Praxis Medical Insights, a similar recommendation is found in 1

Nephrology Referral and Medication Management

• The American Diabetes Association recommends initiating ACE inhibitor or ARB regardless of blood pressure if albuminuria is present, as these medications reduce progressive kidney disease risk 1
• Nephrology referral is indicated if ACR ≥30 mg/g, especially ≥300 mg/g, or if there is uncertainty about the etiology of kidney disease, with the American Diabetes Association and European Heart Association providing guidance on this topic 1, 2

Patient Management and Prognosis

• The European Heart Association states that an eGFR of 46 ml/min places the patient in CKD Stage 3a or borderline Stage 3b, representing "mildly to moderately decreased" kidney function, with elevated cardiovascular risk, particularly if albuminuria is present 3, 4
• Avoiding nephrotoxic agents such as NSAIDs, aminoglycosides, and minimizing contrast dye exposure is recommended by the European Heart Association and Praxis Medical Insights, although the latter is not preferred, a similar recommendation is found in 5
• Assessing volume status before attributing elevated creatinine to intrinsic kidney disease is crucial, as dehydration can cause pre-renal azotemia, with guidance from the American Diabetes Association and European Heart Association on this topic 1, 2